<unk>  is used as a fertility treatment drug for women and/or people with ovaries. Specifically, it is used to prevent premature ovulation in people with ovaries undergoing fertility treatment involving ovarian hyperstimulation that causes the ovaries to produce multiple eggs. When such premature ovulation occurs, the eggs released by the ovaries may be too immature to be used in in-vitro fertilization.<unk>  prevents ovulation until it is triggered by injecting human chorionic gonadotrophin (hCG).<unk>  is administered by a subcutaneous injection of 250 µg once per day during the mid to late follicular phase of a patient's menstrual cycle. Treatment should start on the 5th or 6th day after the start of ovarian stimulation, and the mean duration for its use is five days. Preferably, the subcutaneous injections are delivered in the upper leg, and the patient can be trained to do this themself. Continued use of the drug should take place until the administration of hCG begins. hCG administration is begun when a sufficient number of follicles have developed due to the effects of endogenous and or exogenously administered follicle stimulating hormone.
Ganirelix
Cobicistat
Migalastat
Oprelvekin
Vosoritide
Pravastatin
Fluvastatin
Lovastatin